Trial intelligence / Profile preview

Comparison of Steroid Dosages for Trochanteric Bursitis

NCT02126878Completed

Sponsor
West Virginia University
Start
Apr 2014
Primary completion
Jun 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of triamcinolone in trochanteric bursitis (3 arms), sponsored by West Virginia University. Primary endpoint: Pain Intensity Measured on Visual Analog Scale and Percent Improvement at 3 months. Started Apr 2014; status: completed.

02

Drugs

triamcinolone
03

Conditions

trochanteric bursitis

Beyond the preview

Go deeper on NCT02126878.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02126878.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call